Cederroth, Christopher R. Albrecht, Urs Bass, Joseph Brown, Steven A. Dyhrfjeld-Johnsen, Jonas Gachon, Frederic Green, Carla B. Hastings, Michael H. Helfrich-Förster, Charlotte Hogenesch, John B. Lévi, Francis Loudon, Andrew Lundkvist, Gabriella B. Meijer, Johanna H. Rosbash, Michael Takahashi, Joseph S. Young, Michael Canlon, Barbara 2019-08-06 The importance of circadian biology has rarely been considered in pre-clinical studies, and even more when translating to the bedside. Circadian biology is becoming a critical factor for improving drug efficacy and diminishing drug toxicity. Indeed, there is emerging evidence showing that some drugs are more effective at nighttime than daytime, whereas for others it is the opposite. This suggests that the biology of the target cell will determine how an organ will respond to a drug at a specific time of the day, thus modulating pharmacodynamics. Thus, it is now time that circadian factors become an integral part of translational research. application/pdf https://folia.unifr.ch/global/documents/308269 https://folia.unifr.ch/documents/308269/files/alb_mnd.pdf eng info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cmet.2019.06.019 info:eu-repo/semantics/openAccess License undefined Cell Metabolism. - 2019, vol. 30, no. 2, p. 238–250 info:eu-repo/classification/udc/61 Medicine in the fourth dimension http://purl.org/coar/resource_type/c_6501